H3 G34 mutation assessment for diffuse gliomas in adults: when would testing be most diagnostically useful?
Trejo-Lopez JA, Praska CE, Zepeda Mendoza C, Kollmeyer TM, Raghunathan A, Giannini C, Vaubel RA, Nguyen A, Jentoft ME, Donev K, Zheng G, DiGuardo MA, Kipp BR, Jenkins RB, Ida CM.
Trejo-Lopez JA, et al.
J Neuropathol Exp Neurol. 2022 Dec 19;82(1):93-95. doi: 10.1093/jnen/nlac102.
J Neuropathol Exp Neurol. 2022.
PMID: 36326576
No abstract available.